GlassScriptPhysician profile
Suzanne E Rocklin
NPI 1679719686
$2,428.34
in general payments reported to CMS, 2019-2025
18 companies · $504 in 2025
The $504 reported for 2025 was more than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $201 · 2022: $474 · 2023: $539 · 2024: $710 · 2025: $504.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,753.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,753.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heartflow, INC. | $338.63 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $216.82 | 2022-2023 | Farxiga |
| Gilead Sciences, INC. | $194.65 | 2021-2023 | Epclusa |
| Inspire Medical Systems, INC. | $145.33 | 2024 | Inspire |
| Abiomed | $130.35 | 2025 | |
| Edwards Lifesciences Corporation | $127.82 | 2025 | Sapien 3 Ultra Resilia |
| Janssen Pharmaceuticals, INC | $124.72 | 2022 | |
| Alexion Pharmaceuticals, INC. | $124.25 | 2025 | Strensiq |
| Eisai INC. | $122.07 | 2025 | |
| Amgen INC. | $121.86 | 2024 | Repatha |
| Takeda Pharmaceuticals U.S.A., INC. | $119.00 | 2021 | |
| Abbvie INC. | $117.36 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $103.89 | 2024 | Xifaxan |
| Mylan Specialty L.P. | $101.60 | 2023 | Yupelri |
| Impel Pharmaceuticals INC. | $96.48 | 2023 | Trudhesa |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Xeris Pharmaceuticals, INC. | $95.01 | 2023 | Recorlev |
| Neurocrine Biosciences, INC. | $86.09 | 2022 | |
| Novo Nordisk INC | $62.41 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Suzanne Rocklin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.